Back to search

Sweden· SE-20000713000018

Myocet liposomal 50 mg Pulver, dispersion och vätska till koncentrat till infusionsvätska, dispersion

A medicinal product containing doxorubicin hydrochloride, registered in Sweden by Cheplapharm Arzneimittel GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedMyocet liposomal 50 mg Pulver, disper…ATC—REGISTER NO.SE-20000713000018PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Doxorubicin Hydrochloride
Manufacturer
Cheplapharm Arzneimittel GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20000713000018

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Doxorubicin hydrochloride in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxorubicin hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Adriblastin, Doxorubicin Accord
  • Belgium · Adriblastina Ready To Use, Doxorubicin Accord Healthcare
  • Bulgaria · Доксорубицин Акорд
  • Cyprus · Adriblastina
  • Czechia · Doxorubicin Ebewe, Doxorubicin Medac
  • Germany · Adriacept Blasen-Instillations-Set, Adrimedac
  • Denmark · Adriamycin, Doxorubicin Accord
  • Estonia · Doxorubicin Accord
  • Spain · Doxorubicina Accord, Doxorubicina Aurovitas
  • Finland · Doxorubicin Accord, Doxorubicin Medac
  • France · Adriblastine, Doxorubicin Teva
  • United Kingdom (Northern Ireland) · Doxorubicin Accord Healthcare, Doxorubicin Hydrochloride Medac
  • Greece · Adriblastina, Doxiprol
  • Croatia · Doxorubicin Pliva, Sindroxocin
  • Hungary · Doxorubicin Accord, Doxorubicin Sandoz
  • Ireland · Doxorubicin Accord Healthcare Ireland, Doxorubicin Rivopharm
  • Iceland · Caelyx Pegylated Liposomal, Doxorubicin Medac
  • Italy · Adriblastina, Doxorubicin Teva
  • Liechtenstein · Caelyx Pegylated Liposomal, Myocet Liposomal
  • Lithuania · Doxorubicin Accord, Doxorubicin Ebewe
  • Luxembourg · Adriblastina Ready To Use, Doxorubicine Teva
  • Latvia · Doxorubicin Accord
  • Malta · Doxorubicin Accord Healthcare
  • Netherlands · Doxorubicin Hydrochloride Eugia, Doxorubicine Accord
  • Norway · Adriamycin, Caelyx Pegylated Liposomal
  • Poland · Doxorubicin Ebewe, Doxorubicinum Accord
  • Portugal · Doxorrubicina Accord, Doxorrubicina Aurovitas
  • Romania · Doxlox, Doxorubicină Accord
  • Slovenia · Doksorubicin Accord, Doksorubicin Sandoz
  • Slovakia · Doxorubicin Medac, Doxorubicin Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/22889208-2784-478d-8a70-2121c26a08fa
GET /v1/drugs/22889208-2784-478d-8a70-2121c26a08fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EMA",
    "EPAR"
  ],
  "se_npl_id": "20000713000018",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20000713000018",
  "product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/myocet-liposomal"
}

See everything about doxorubicin hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.